<DOC>
	<DOCNO>NCT00812032</DOCNO>
	<brief_summary>The efficacy low dose aspirin appear substantially low diabetic patient , compare patient without diabetes . The aim investigator study test laboratory response different dose aspirin type 2 Diabetes Mellitus . The investigator compare regular dose 75mg daily 75 mg twice daily 320 mg daily . The hypothesis study twice daily dose aspirin may improve response aspirin .</brief_summary>
	<brief_title>Evaluation Antiplatelet Effects Different Dosages Aspirin Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Type 2 DM micro macroangiopathy . HbA1c 69 % ( MonoS method ) . Need , already ongoing aspirin treatment . Age 5075 year Antecubital forearm vein allow technically good sample platelet study Diet control DM . Acute ischemic stroke , acute coronary syndrome , ( myocardial infarction unstable angina pectoris ) , revascularization PCI bypass surgery within last 6 month . Acute chronic kidney disease ( Pcystatin C within reference interval ) Acute chronic liver disease ( ALAT â‰¤2 time upper reference value ) . A history gastric duodenal ulcer disease . Need treatment anticoagulant , clopidogrel , NSAID 's , thiazolidinediones . Thrombocytopenia ( platelet count &lt; 150 x 109/L ) Anticipated need alteration concomitant drug therapy course study . Enrollment another clinical study . Contraindication ( ) aspirin treatment .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>NIDDM</keyword>
	<keyword>Aspirin</keyword>
	<keyword>platelet inhibition</keyword>
	<keyword>Aspirin treatment</keyword>
</DOC>